Navigation Links
Screening for Ischemia in Asymptomatic Patients With Type 2 Diabetes: Five- Year Outcomes in the DIAD Study
Date:9/13/2008

Study Shows Systematic Screening May Not Be Necessary For Diabetic Patients

BOSTON, Sept. 13 /PRNewswire-USNewswire/ -- There are 21 million patients with Type 2 diabetes in the United States alone. Coronary artery disease (CAD) is a major cause of morbidity in patients with diabetes. Silent myocardial ischemia is common, and cardiac death or myocardial infarction may be the first manifestation of CAD.

Data from the Detection of Ischemia in Asymptomatic Diabetics (DIAD) Study, presented today at the American Society of Nuclear Cardiology Annual Scientific Session, seeks to assess the prevalence of silent myocardial ischemia and discern whether CAD screening should be offered to all people with type 2 diabetes. According to the most recent information from the study, screening does not provide a significant benefit to this patient population.

"The DIAD study is the first large prospective study addressing the issue of whether a strategy of systematic screening for silent coronary artery disease alters cardiac outcome," said Dr. Frans Wackers, who will present results from the study at today's meeting.

Overall, 1,123 diabetic patients without symptomatic or previously diagnosed CAD were randomized to either screening with myocardial perfusion imaging or standard care without screening. After an average 5-year follow- up, researchers found a low overall cardiac event rate and no difference between the two groups. Thus, unexpectedly, diabetic patients without known CAD have an overall highly favorable five-year prognosis with contemporary therapy, such as aspirin, statins, and ACE-inhibitors.

"Systematic screening cannot be recommended in asymptomatic patients with diabetes," commented Dr. Wackers. "However, targeted screening, involving close clinical follow-up and clinically driven diagnostic testing, is appropriate. Using the latter approach, about 30% of initially asymptomatic patients had stress myocardial perfusion imaging in the standard-care arm of the DIAD study."

Dr. Frans Wackers will present this study, "Screening for Ischemia in Asymptomatic Patients with Type 2 Diabetes: Five-Year Outcomes in the DIAD Study" Saturday, September 13, 2008 at 11:40 a.m. in Room 306.

The American Society of Nuclear Cardiology (ASNC) is the leader in education, advocacy, and quality for the field of nuclear cardiology. Serving more than 5,000 individuals in over 50 countries, ASNC is the only professional association dedicated to the dynamic subspecialty of nuclear cardiology.


'/>"/>
SOURCE American Society of Nuclear Cardiology
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. Trana Discovery and Southern Research Institute Announce the First RNA-RNA High Throughput Drug Screening Assay Platform for HIV Antivirals
2. Preimplantation Genetic Diagnosis International Society Refutes American Society of Reproductive Medicine Opinion - States Preimplantation Genetic Screening is Beneficial When Performed in Experienced Centers
3. Experts Call for Widespread Use of Memory Screenings and Emphasize Value of Early Detection of Dementia
4. Innovative Brain Scanning for Alzheimers Screening Unveiled
5. Gen-Probe Submits U.S. Regulatory Application for Additional Approval of PROCLEIX(R) ULTRIO(R) Blood Screening Assay
6. ACR Supports American Cancer Society Inclusion of CT Colonography (Virtual Colonoscopy) as Recommended Screening Tool for Colorectal Cancer in New Screening Guidelines
7. Lung Cancer Alliance Commends NCCN on Screening Guidelines
8. Blood Spot Technology at ZRT Highlighted in March Issue of Journal of Diabetes Science & Technology - A Convenient Alternative to Serum Testing for Health Screening
9. Adding Breast Ultrasound Screening to Mammography Reveals Cancers not Seen on Mammography Alone in Women at Increased Risk for Breast Cancer
10. Karmanos Doctors Urge Increased Screening for Previously Treated Lung Cancer Patients, Especially Young Women
11. Task Force Recommends Screening for Hearing Loss in All Newborns
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... N.C. , Feb. 8, 2016  Avista Pharma ... Eric Setzer as Chief Financial Officer (CFO). Mr. ... twenty years of experience in various roles within growing ... Pharma, he served as the Executive Director of Finance ... in Raleigh, NC . Previously, Mr. ...
(Date:2/8/2016)... , Feb. 8, 2016 Velano Vascular, ... experience for hospitalized patients and their practitioners, announced today ... in funding. Velano will use the proceeds from this ... financing completed in January 2015, to support the development ... adult and pediatric populations. Philadelphia ...
(Date:2/8/2016)... -- Vestagen Technical Textiles, Inc., a medical technology company ... other demanding applications, today announced it has named ... Dale Pfost , PhD, who was serving as interim ... Vestagen,s Board of Directors. ® , the ... that combines fluid repellent, antimicrobial and breathability properties. VESTEX ...
Breaking Medicine Technology:
(Date:2/8/2016)... ... February 08, 2016 , ... ... redesigned website, federallabs.org . The site houses a wealth of federal resources ... technologies through the process called technology transfer (T2). As a network of over ...
(Date:2/8/2016)... ... February 08, 2016 , ... ... Houma, LA, celebrates the beginning of a new charity campaign. As part of ... Appointed Special Advocates (CASA). In the belief that children deserve a voice, and ...
(Date:2/8/2016)... ... February 08, 2016 , ... Brenton Engineering , ... bags, and flow wrapped products at WestPack 2015, February 9-11, in Anaheim, California. ... up to semi-automatic or fully-automatic case packing with a small footprint, rugged, highly ...
(Date:2/8/2016)... Island, SC (PRWEB) , ... February 08, 2016 , ... ... surrounding areas with a vital new community enrichment program, has teamed up with Citizens ... women and children suffering from intimate abuse. To support all those victimized by the ...
(Date:2/8/2016)... CA (PRWEB) , ... February 08, 2016 , ... Delta ... $792,000 to help combat pancreatic cancer. , Gary D. Radine, who recently retired as ... was the American Cancer Society’s 2015 CEO of the Year , helped lead ...
Breaking Medicine News(10 mins):